Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

United Health Products (UEEC) Convertible Debt (2019 - 2025)

United Health Products (UEEC) has disclosed Convertible Debt for 6 consecutive years, with $927500.0 as the latest value for Q3 2025.

  • On a quarterly basis, Convertible Debt rose 518.33% to $927500.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $927500.0, a 518.33% increase, with the full-year FY2024 number at $557500.0, changed N/A from a year prior.
  • Convertible Debt was $927500.0 for Q3 2025 at United Health Products, up from $847500.0 in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $927500.0 in Q3 2025 to a low of $25811.0 in Q1 2021.
  • A 4-year average of $385031.1 and a median of $261000.0 in 2022 define the central range for Convertible Debt.
  • Peak YoY movement for Convertible Debt: surged 2966.67% in 2021, then fell 6.52% in 2022.
  • United Health Products' Convertible Debt stood at $115000.0 in 2021, then decreased by 6.52% to $107500.0 in 2022, then skyrocketed by 418.6% to $557500.0 in 2024, then surged by 66.37% to $927500.0 in 2025.
  • Per Business Quant, the three most recent readings for UEEC's Convertible Debt are $927500.0 (Q3 2025), $847500.0 (Q2 2025), and $647500.0 (Q1 2025).